CHA Vaccine Research Institute (KOSDAQ:261780)
South Korea
· Delayed Price · Currency is KRW 3,985.00
+125.00 (3.24%)
At close: Apr 28, 2026
KOSDAQ:261780 Revenue
In the year 2025, CHA Vaccine Research Institute had annual revenue of 158.62M KRW, down -57.21%. CHA Vaccine Research Institute had revenue of -10.00 in the quarter ending December 31, 2025.
Revenue
158.62M
Revenue Growth
-57.21%
P/S Ratio
659.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
104.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 158.62M | -212.04M | -57.21% |
| Dec 31, 2024 | 370.66M | 76.53M | 26.02% |
| Dec 31, 2023 | 294.12M | 114.64M | 63.87% |
| Dec 31, 2022 | 179.48M | -320.52M | -64.10% |
| Dec 31, 2021 | 500.00M | 422.20M | 542.70% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SunBio,Inc. | 2.17B |
| TegoScience | 5.94B |
| KoBioLabs | 69.29B |
| CTCBIO | 123.77B |
| Choong Ang Vaccine Laboratory | 39.19B |
| Quratis | 2.46B |
| Cell Biotech | 53.13B |
| Naturalendo Tech | 22.23B |